Latest from #CancerEvo member Matt Froid:
Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition
#cancer #januseffect #aml #abm […]
Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition
#cancer #januseffect #aml #abm […]
Original post on fediscience.org
fediscience.org
March 20, 2026 at 10:56 AM
Latest from #CancerEvo member Matt Froid:
Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition
#cancer #januseffect #aml #abm […]
Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition
#cancer #januseffect #aml #abm […]
Latest work from #CancerEvo @moffittnews.bsky.social @mathonco.bsky.social member Matt Froid working with @rrockne.bsky.social and friends at @cityofhope.bsky.social using #MathOnco to study the #JanusEffect in #AML:
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition - npj Systems Biology and Applications
npj Systems Biology and Applications - Overcoming vascular niche–mediated TKI resistance in acute myeloid leukemia through miR-126 inhibition
www.nature.com
March 20, 2026 at 12:29 PM
Latest work from #CancerEvo @moffittnews.bsky.social @mathonco.bsky.social member Matt Froid working with @rrockne.bsky.social and friends at @cityofhope.bsky.social using #MathOnco to study the #JanusEffect in #AML:
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Congrats Dr. @alexsteinresearch.bsky.social and also Alex's PhD supervisor @benjaminwerner.bsky.social for an excellent body of doctoral work pushing the frontiers of #mathonco and #cancerevo
March 21, 2025 at 9:40 AM
Congrats Dr. @alexsteinresearch.bsky.social and also Alex's PhD supervisor @benjaminwerner.bsky.social for an excellent body of doctoral work pushing the frontiers of #mathonco and #cancerevo